Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. metabolism drug
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Metabolism Drug Articles & Analysis

14 news found

CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency   

CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency  

These microneedles are composed of a biocompatible material that dissolves upon insertion, allowing for controlled and targeted drug release. The dissolving microneedle preparation services offered by CD Formulation provide a comprehensive solution for pharmaceutical companies looking to optimize drug delivery. ...

ByCD Formulation


Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

This enzyme plays a fundamental role in various biological processes including gene expression, protein function, and metabolic activity. Thus, having a quality and reliable source of SAHH is vital for research institutions and industries to advance their understanding and application of this pivotal enzyme. ...

ByCreative Enzymes


Araris Biotech appoints Bernd Schlereth as Chief Development Officer

Araris Biotech appoints Bernd Schlereth as Chief Development Officer

Araris Biotech AG, a company pioneering antibody-drug conjugate (ADC)-linker technology, announced today that it has recruited Dr. ...

ByAraris Biotech AG


Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Tumor drug resistance has long been a key direction of cancer research. Meanwhile, complex factors and multiple mechanisms are known to induce drug resistance occurrence or reoccurrence, covering tumor heterogeneity, DNA damage repair, apoptosis inhibition, epithelial-mesenchymal transition, increased drug excretion or reduced absorption, ...

ByCreative Proteomics


Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes

Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes

In the paper, ‘Predicting Regioselectivity of AO, CYP, FMO and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning’, the team combined existing experimental results, quantum mechanics and machine learning to build predictive models for drug metabolism. [1] The research will underpin the development of new ...

ByOptibrium Ltd.


CD Formulation Plays a Role in Developing Drug Delivery Systems

CD Formulation Plays a Role in Developing Drug Delivery Systems

Choosing the most appropriate delivery system has tremendous benefits, including but not limited to controlled release of drugs, enhanced drug targeting, improved solubility and bioavailability of drugs. In the past decade, several new drug delivery systems have been formulated, in the hope to provide promising alternative routes ...

ByCD Formulation


Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

After digestion, the amino acid sequence may undergo further amino acid modifications and be metabolized by hepatic P450 enzymes. In vivo metabolite studies of protein/peptide drugs usually focus on non-specific enzymatic cleavage or modification of amino acids, P450 enzyme metabolism, and multi-charge distribution. Metabolite identification of ...

ByCreative Proteomics


Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery

Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery

Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design. ...

ByIktos


Alfa Chemistry Now Offers Pharmaceutical and Drug Standards for Drug Discovery

Alfa Chemistry Now Offers Pharmaceutical and Drug Standards for Drug Discovery

Today it announces to add pharmaceutical and drug standards to its already rich offering of chromatography standards. ...

ByAlfa Chemistry


Lonza and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes for Use on Innovative Organ-on-a-chip Range

Lonza and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes for Use on Innovative Organ-on-a-chip Range

Maureen Bunger, Senior Product Manager, ADME-Tox Solutions, Lonza Cell and Gene, commented: “Today’s drug discovery success is hugely dependent on performing experiments using the right biological model to best reflect in vivo environments. ...

ByLonza Group Ltd


Microvi and Nexilico Develop Powerful Computational Platform for Gut Microbiome funded by NIH

Microvi and Nexilico Develop Powerful Computational Platform for Gut Microbiome funded by NIH

The in silico platform reduces the cost and timeframe of drug development by reducing the need for iterative pre-clinical experiments and better directing clinical trials, while increasing the effectiveness of the therapeutics themselves. ...

ByMIcrovi Biotech, Inc.


Wired: This startup wants to stop deaths from cardiac arrest?

Wired: This startup wants to stop deaths from cardiac arrest?

“There are a great number of underlying mechanisms that can trigger a cardiac arrest, such as an airway obstruction, a metabolic imbalance, a drug overdose, a critical bleeding, a collapsed lung,” says Frost. ...

ByNeurescue


UA College of Pharmacy researchers link liver disease and drug metabolism

“If any clinician is going to provide precision medicine, they’ll need to know the ability of the liver and kidneys to metabolize and eliminate drugs,” he emphasizes. More than 110,000 people are estimated to die each year from adverse drug reactions, which is when the correct drug is given in an appropriate ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Studies Show Genetic Variations in Multiple Chemical Sensitivity

Studies Show Genetic Variations in Multiple Chemical Sensitivity

'According to the study the glutathione S-transferases act to inactivate chemicals so people without these GSTM1 and GSTT1 genes are less able to metabolize environmental chemicals,” said Lourdes Salvador, Founder and President of MCS America. “If a person cannot metabolize chemicals they build up in the body and cause disturbances in normal body function,” added ...

ByMCS America

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT